Endothelial nitric oxide in humans in health and disease

International Journal of Experimental Pathology

Volumn 80, Issue 6, 1999, Pages 291-303

  Vallance, Patrick ^a   Hingorani, Aroon ^b  

^a Centre for Clinical Pharmacology   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHEMICAL REACTION; ENZYME ACTIVITY; ENZYME INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR ENDOTHELIUM; VASODILATATION;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATION;

EID: 0033370341     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1999.00137.x     Document Type: Review

References (170)

1. Armour K.E. & Ralston S.H. (1998) Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139, 799-802.
2. Arngrimsson R., Hayward C., Nadaud S. et al. (1998) Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am. J. Hum. Genet. 61, 354-362.
3. Bath P.M., Hassall D.G., Gladwin A.M., Palmer R.M. & Martin J.F. (1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. 11, 254-260.
4. Baydoun A.R., Emery P.W., Pearson J.D. & Mann G.E. (1990) Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 173, 940-948.
5. Baylis C. & Vallance P. (1998) Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system? [editorial]. Curr. Opin. Nephrol. Hypertens. 7, 59-62.
6. Beckmann J.S. & Koppenol W.H. (1996) Nitric oxide, superoxide, and peroxynitrite. the good, the bad, and the ugly. Am. J. Physiol. 271, C1424-C1437.
7. Bhagat K. & Vallance P. (1996) Inducible nitric oxide synthase in the cardiovascular system [editorial]. Heart 75, 218-220.
8. Bhagat K., Hingorani A., Palacios M., Charles I. & Vallance P. (1999) Cytokine-induced venodilatation in humans. eNOS masquerading as iNOS. Cardiovasc. Res. 41, 754-764.
9. Biffl W.L., Moore E.E., Moore F.A. & Barnett C. (1996) Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM) -1. J. Surg. Res. 63, 328-332.
10. Bode Boger S.M., Boger R.H., Creutzig A. et al. (1994) L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin. Sci. Colch. 87, 303-310.
11. Boger R.H., Bode Boger S.M. & Frolich J.C. (1996) The L-arginine-nitric oxide pathway, role in atherosclerosis and therapeutic implications. Atherosclerosis 127, 1-11.
12. Boger R.H., Bode-Boger S.M., Thiele W., Junker W., Alexander K. & Frolich J.C. (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95, 2068-2074.
13. Borutaite V. & Brown G.C. (1996) Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem. J. 315, 295-299.
14. Brayden J.E. & Large W.A. (1986) Electrophysiological analysis of neurogenic vasodilatation in the isolated lingual artery of the rabbit. Br. J. Pharmacol. 89, 163-171.
15. Bredt D.S. & Snyder S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87, 682-685.
16. Brown G.G. & Cooper C.E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356, 295-298.
17. Brown G.G. (1995) Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369, 136-139.
18. Brown G.C. (1997) Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration, implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol. Cell Biochem. 174, 189-192.
19. Bruning T.A., Hendriks M.G., Chang P.C., Kuypers E.A. & Van Zwieten P.A. (1994) In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ. Res. 74,912-919.
20. Buga G.M., Gold M.E., Fukuto J.M. & Ignarro L.J. (1991) Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17, 187-193.
21. Busconi L. & Michel T. (1993) Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268, 8410-8413.
22. Busconi L. & Michel T. (1994) Endothelial nitric oxide synthase membrane targeting. Evidence against involvement of a specific myristate receptor. J. Biol. Chem. 269, 25016-25020.
23. Calver A., Collier J., Leone A., Moncada S. & Vallance P. (1993) Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J. Hum. Hypertens. 7, 193-194.
24. G-monomethyl-L arginine in patients with hypertension, the nitric oxide dilator mechanism appears abnormal. J. Hypertens. 10, 1025-1031.
25. Calver A., Collier J. & Vallance P. (1992b) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes mellitus. J. Clin. Invest 90, 2548-2554.
26. Capelli Bigazzi M., Rubattu S., Battaglia C. et al. (1997) Effects of high cholesterol and atherogenic diets on vascular relaxation in spontaneously hypertensive rats. Am. J. Physiol. 273, H647-H654.
27. Cayatte A., Palacino J., Horten K. & Cohen R.A. (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolaemic rabbits. Arterioscler. Thromb. Vasc. Biol. 14, 753-759.
28. Celermajer D.S., Sorensen K.E., Georgakopoulos D. et al. (1993). Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88, 2149-2155.
29. Celermajer D.S., Sorensen K.E., Gooch V.M. et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111-1115.
30. Charles I.G., Scorer C.A., Moro M.A. et al. (1996) Expression of human nitric oxide synthase isozymes. Meth Enzymol. 268, 449-460.
31. Chester A.H., O'Neil G.S., Moncada S., Tadjkarimi S. & Yacoub M.H. (1990) Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 336, 897-900.
32. Chowienczyk P.J., Cockcroft J.R. & Ritter J.M. (1993) Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br. J. Pharmacol. 110, 736-738.
33. Chowienczyk P.J., Watts G.F., Cockcroft J.R., Brett S.E. & Ritter J.M. (1994) Sex differnces in endothelial function in hypercholesterolaemia subjects. Lancet 344, 305-306.
34. Cleeter M.W., Cooper J.M., Darley Usmar V.M., Moncada S. & Schapira A.H. (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345, 50-54.
35. Cockcroft J.R., Chowienczyk P.J., Benjamin N. & Ritter J.M. (1994) Preserved endothelium-dependent vasodilatation in patients with essential hypertension [published erratum appears in N. Engl. J. Med. 1995 May 25; 332 (21). 1455]. N. Engl. J. Med. 330, 1036-1040.
36. Collier J. & Vallance P. (1990) Biphasic response to acetylcholine in human veins in vivo. The role of the endothelium. Clin. Sci. Colch. 78, 101-104.
37. Collins P., Burman J., Chung H.I. & Fox K. (1993) Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 87, 80-85.
38. Cosentino F. & Luscher T. (1999) Tetrahydrobiopterin and endothelial nitric oxide synthase activity. J.Card. Res. 43, 274-278.
39. Corson M.A., James N.L., Latta S.E., Nerem R.M., Berk B.C. & Harrison D.G. (1996) Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 79, 984-991.
40. Crane B.R., Arvai A.S., Gacchui R. et al. (1997) The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278, 425-431.
41. Crawley D.E., Liu S.F., Evans T.W. & Barnes P.J. (1990) Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br. J. Pharmacol. 101, 166-170.
42. Darley-Usmar V., Wiseman H. & Halliwell B. (1995) Nitric oxide and oxygen radicals, a question of balance. FEBS Lett. 369, 131-135.
43. Davies P.F. (1995) Flow-mediated endothelial mechanotransduction. Pnysiol. Rev. 75, 519-560.
44. De Caterina R., Libby P., Peng H.B. et al. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60-68.
45. Dijkhorst Oei L.T. & Koomans H.A. (1998) Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans. Nephrol. Dial. Transplant. 13, 587-593.
46. Eis A.L., Brockman D.E., Pollock J.S. & Myatt L. (1995) Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta. 16, 113-126.
47. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A. & Michel T. (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271, 22810-22814.
48. Fickling S.A., Williams D., Vallance P., Nussey S.S. & Whitley G.S. (1993) Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia [letter]. Lancet 342, 242-243.
49. Fleming I., Bauersachs J. & Busse R. (1997) Calcium-dependent and calcium-independent activation ot the endothelial NO synthase. J. Vase. Res. 34, 165-174.
50. Forte P., Copland M., Smith L.M., Milne E., Sutherland J. & Benjamin N. (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349, 837-842.
51. Furchgott R.F. (1984) The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24, 175-197.
52. Furchgott R.F. (1990) The 1989 Ulf von Euter lecture. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol. Scand. 139, 257-270.
53. Furchgott R.F. & Jothianandan D. (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28, 52-61.
54. Furchgott R.F. & Zawadzki J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
55. Garcia Cardena G., Fan R., Stern D.F., Liu J. & Sessa W.C. (1996) Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271, 27237-27240.
56. Garg U.C. & Hassid A. (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1774-1777.
57. Giuffre A., Sarti P., D'Itri E., Buse G., Soulimane T. & Brunori M. (1996) On the mechanism of inhibition of cytochrome c oxidase by nitric oxide. J. Biol. Chem. 271, 33404-33408.
58. Gow A.J. & Stamler U.S. (1998) Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391, 169-173.
59. Greenberg B., Rhoden K. & Barnes P.J. (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am. J. Physiol. 252, H434-H438.
60. Grunfeld S., Hamilton C.A., Mascaros S., Dominiczak A.F., Bohr D.F. & Malinski T. (1995) Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 26, 854-857.
61. Haynes W.G., Noon J.P., Walker B.R. & Webb D.J. (1993) Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertens. 11, 1375-1380.
62. Haynes W.G., Hand M.F., Dockrell M.E. et al. (1997) Physiological role of nitric oxide in regulation of renal function in humans. Am. J. Physiol. 272, F364-F371.
63. Hibbs J.B.J.R., Westenfelder C., Taintor R. et al. (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89, 867-877.
64. Hibi K., Ishigami T., Tamura K. et al. (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32, 521-526.
65. Hingorani A.D., Jia H., Stevens P.A., Monteith M.S. & Brown M.J. (1995) A common variant in exon 7 of the endothelial constitutive nitric oxide synthase gene. Clin. Sci. 88, 21P (Abstract).
66. Hingorani A.D. (1997) Studies of candidate genes for essential hypertension and coronary artery disease. PhD Thesis. Department of Medicine, Gonville and Caius College, Cambridge University.
67. Hingorani A.D., Liang C.F., Fatibene J. et al. (1999) A common variant of the endothelial nitric oxide synthase gene is a risk factor for coronary atherosclerosis in the East Anglian region of the UK. Circulation 100, 1515-1520.
68. Hobbs A.J. (1997) Soluble guanylate cyclase. the forgotten sibling. Trends. Pharmacol. Sci. 18, 484-490.
69. Huang P.L., Huang Z., Mashimo H. et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242.
70. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E. & Chaudhuri G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84, 9265-9269.
71. Ignarro L.J. (1990a) Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide, a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67, 1 -7.
72. Ignarro L.J. (1990b) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30, 535-560.
73. Imaizumi T., Hirooka Y., Masaki H. et al. (1992) Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 20, 511-517.
74. Inoue N., Venema R.C., Sayegh H.S., Ohara Y., Murphy T.J. & Harrison D.G. (1995) Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler. Thromb. Vasc. Biol. 15, 1255-1261.
75. Janssens S., Flaherty D., Nong Z. et al. (1998) Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97, 1274-1281.
76. Jia L, Bonaventura C., Bonaventura J. & Stamler U.S. (1996) S-nitrosohaemoglobin. a dynamic activity of blood involved in vascular control. Nature 380, 221-226.
77. Jovanovic A., Grbovic L. & Tulic I. (1994) Predominant role for nitric oxide in the relaxation induced by acetylcholine in human uterine artery. Hum. Reprod. 9, 387-393.
78. Kanai A.J., Strauss H.C., Truskey G.A., Crews A.L., Grunfeld S. & Malinski T. (1995) Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ. Res. 77, 284-293.
79. Kanamaru K., Waga S., Fujimoto K., Itoh H. & Kubo Y. (1989) Endothelium-dependent relaxation of human basilar arteries. Stroke 20, 1208-1211.
80. Keaney J.F., Simon D.I., Stamler J.S. et al. (1993) NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91, 1582-1589.
81. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W. & Medford R.M. (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93, 9114-9119.
82. Kleinert H., Wallerath T., Euchenhofer C., Ihrig-Biedert I., Li H. & Forstermann U. (1998) Estrogens increase transcription of the human endothelial nitric oxide synthase gene. Hypertension 31, 582-588.
83. Kuo L., Davis M.J. & Chilian W.M. (1990) Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am. J. Physiol. 259, H1063-H1070.
84. Lamontagne D., Pohl U. & Busse R. (1992) Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ. Res. 70, 123-130.
85. Lansman J.B., Hallam T.J. & Rink T.J. (1987) Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325, 811-813.
86. Lansman J.B. (1988) Endothelial mechanosensors. Going with the flow. Nature 331, 481-482.
87. Lawrie G.M., Weilbacher D.E. & Henry P.D. (1990) Endothelium-dependent relaxation in human saphenous vein grafts. Effects of preparation and clinicopathologic correlations. J. Thorac. Cardiovasc. Surg. 100, 612-620.
88. Lee J.S., Adrie C., Jacob H.J., Roberts J.D.J.R., Zapol W.M. & Bloch K.D. (1996) Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ. Res. 78, 337-342.
89. Lefroy D.C., Crake T., Uren N.G., Davies G.J. & Maseri A. (1993) Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 88, 43-54.
90. Leiper J., MacAllister R., Whitley G. et al. (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology to microbial arginine deiminases. Biochem. J. 343, 209-214.
91. Lieberman E.H., Gerhard M.D., Uehata A. et al. (1996) Flow-induced vasodilation of the human brachial artery is impaired in patients >40 years of age with coronary artery disease. Am. J. Cardiol. 78, 1210-1214.
92. Linder L., Kiowski W., Buhler F.R. & Luscher T.F. (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81, 1762-1767.
93. Loke K.E., Sobey C.G., Dusting G.J. & Woodman O.L. (1994) Requirement for endothelium-derived nitric oxide in vasodilation produced by stimulation of cholinergic nerves in rat hindquarters. Br. J. Pharmacol. 112, 630-634.
94. Luscher T.F., Cooke J.P., Houston D.S., Neves R.J. & Vanhoutte P.M. (1987) Endothelium-dependent relaxations in human arteries. Mayo Clin. Proc. 62, 601-606.
95. Luscher T.F. & Vanhoutte P.M. (1988) Endothelium-dependent responses in human blood vessels. Trends. Pharmacol. Sci. 9, 181-184.
96. Luscher T.F., Yang Z., Tschudi M. et al. (1990) Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ. Res. 66, 1088-1094.
97. MacAllan D.C., Smith L.M., Ferber J. et al. (1997) Measurement of NO synthesis in humans by L-[15N2]arginine: application to the response to vaccination. Am. J. Physiol. 272, R1888-R1896.
98. MacAllister R.J., Fickling S.A., Whitley G.S. & Vallance P. (1994a) Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol. 112, 43-48.
99. MacAllister R.J., Whitley G.S. & Vallance P. (1994b) Effects of guanidino and uremie compounds on nitric oxide pathways. Kidney Int. 45, 737-742.
100. MacAllister R.J. & Vallance P. (1996) Systemic vascular adaptation to increases in blood volume, the role of the blood-vessel wall [editorial]. Nephrol. Dial. Transplant. 11, 231-234.
101. MacAllister R.J., Parry H., Kimoto M. et al. (1996a) Regulation of nitric oxide synthesis by dimethylarginine dimethylamino-hydrolase. Br. J. Pharmacol. 119, 1533-1540.
102. MacAllister R.J., Rambausek M.H., Vallance P., Williams D., Hoffmann K. H. & RITZ E. (1996b) Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol. Dial. Transplant. 11, 2449-2452.
103. MacRitchie A.N., Jun S.S., Chen Z. et al. (1997) Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ. Res. 81, 355-362.
104. Markus H.S., Ruigrok Y., Ali N. & Powell J.F. (1998) Endothelial nitric oxide synthase exon 7 polymorphism, ischaemic cerebro-vascular disease, and carotid atheroma. Stroke 29, 1908-1911.
105. Marsden P.A., Heng H.H., Scherer S.W. et al. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268, 17478-17488.
106. Mayer B., Schmidt K., Humbert P. & Bohme E. (1989) Biosynthesis of endothelium-derived relaxing factor, a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem. Biophys. Res. Commun. 164, 678-685.
107. Mehta S., Stewart D.J. & Levy R.D. (1996) The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans. Chest 109, 1550-1555.
108. Meredith I.T., Currie K.E., Anderson T.J., Roddy M.A., Ganz P. & Creager M.A. (1996) Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am. J. Physiol. 270, H1435-H1440.
109. Michel J.B., Feron O., Sase K., Prabhakar P. & Michel T. (1997) Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 272, 25907-25912.
110. Michel T., Li G.K. & Busconi L. (1993) Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90, 6252-6256.
111. Michel T. & Feron O. (1997) Nitric oxide synthases. which, where, how, and why? J. Clin. Invest. 100, 2146-2152.
112. Miyahara K., Kawamoto T., Sase K. et al. (1994) Cloning and structural organisation of the human endothelial nitric oxide synthase gene. Eur. J. Biochem. 223, 719-726.
113. Miyamoto Y., Saito Y., Kajiyama N. et al. (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32, 3-8.
114. Mollace V., Salvemini D., Anggard E. & Vane J. (1991) Nitric oxide from vascular smooth muscle cells, regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 104, 633-638.
115. Mulsch A., Bassenge E. & Busse R. (1989) Nitric oxide synthesis in endothelial cytosol. evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedebergs Arch. Pharmacol. 340, 767-770.
116. Myatt L, Brockman D.E., Eis A.L. & Pollock J.S. (1993) Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta. 14, 487-495.
117. Nadaud S., Bonnardeaux A., Lathrop M. & Soubrier F. (1994) Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 198, 1027-1033.
118. Nakaki T., Nakayama M. & Kato R. (1990) Inhibition by nitric oxide and nitric oxide-producing vasodilators ot DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189, 347-353.
119. 2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler. Thromb. Vasc. Biol. 14, 746-752.
120. Noris M., Morigi M., Donadelli R. et al. (1995) Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76, 536-543.
121. O'Neil G.S., Chester A.H., Allen S.P. et al. (1991) Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft. J. Thorac. Cardiovasc. Surg. 102, 561-565.
122. Olesen S.P., Clapham D.E. & Davies P.F. (1988) Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331, 168-170.
123. Palmer R.M., Ferrige A.G. & Moncada S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
124. Penny W.F., Rockman H., Long J. et al. (1995) Heterogeneity of vasomotor response to acetylcholine along the human coronary artery. J. Am. Coll. Cardiol. 25, 1046-1055.
125. Pohl U., Holtz J., Busse R. & Bassenge E. (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8, 37-44.
126. Radomski M.W., Palmer R.M. & Moncada S. (1987a) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92, 181-187.
127. Radomski M.W., Palmer R.M. & Moncada S. (1987b) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2, 1057-1058.
128. Radomski M.W., Palmer R.M. & Moncada S. (1990) Characterization of the L-arginine. nitric oxide pathway in human platelets. Br. J. Pharmacol. 101, 325-328.
129. Ranjan V., Xiao Z. & Diamond S.L. (1995) Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am. J. Physiol. 269, H550-H555.
130. Robinson L.J. & Michel T. (1995) Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc. Natl. Acad. Sci. USA 92, 11776-11780.
131. Robinson L.J., Busconi L. & Michel T. (1995) Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J. Biol. Chem. 270, 995-998.
132. Rodriguez Crespo I., Gerber N.C. & Ortiz De Montellano P.R. (1996) Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J. Biol. Chem. 271, 11462-11467.
133. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D. & Webb R.C. (1996) Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78, 225-230.
134. Sase K. & Michel T. (1995) Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 57, 2049-2055.
135. Schoeffter P., Dion R. & Godfraind T. (1988) Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery. Br. J. Pharmacol. 95, 531 -543.
136. Sessa W.C., Garcia Cardena G., Liu J. et al. (1995) The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J. Biol. Chem. 270, 17641-17644.
137. Shaul P.W., North A.J., Wu L.C. et al. (1994) Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J. Clin. Invest. 94, 2231-2236.
138. Shaul P.W., Smart E.J., Robinson L.J. et al. (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271, 6518-6522.
139. Shimasaki Y., Yasue H., Yoshimura M. et al. (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J. Am. Coll. Cardiol. 31, 1506-1510.
140. Siegel G., Malmsten M., Klussendorf D., Walter A., Schnalke F. & Kauschmann A. (1996) Blood-flow sensing by anionic biopolymers. J. Auton. Nerv. Syst. 57, 207-213.
141. Stamler J.S., Loh E., Roddy M.A., Currie K.E. & Creager M.A. (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89, 2035-2040.
142. Stamler J.S.,Jia L., Eu J.P. et al. (1997) Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276, 2034-2037.
143. Takahashi M., Ikeda U., Masuyama J., Funayama H., Kano S. & Shimada K. (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine. 8, 817-821.
144. Thom S., Hughes A., Martin G. & Sever P.S. (1987) Endothelium-dependent relaxation in isolated human arteries and veins. Clin. Sci. 73, 547-552.
145. Toda N. & Okamura T. (1989) Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. Am. J. Physiol. 257, H988-H995.
146. Topper J.N., Cai J., Falb D., Gimbrone M.A. & J.R. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli, cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc. Natl. Acad. Sci. USA 93, 10417-10422.
147. Torres J., Davies N., Darley Usmar V.M. & Wilson M.T. (1997) The inhibition of cytochrome c oxidase by nitric oxide using S-nitrosoglutathione. J. Inorg. Biochem. 66, 207-212.
148. Uematsu M., Ohara Y., Navas J.P. et al. (1995) Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269, C1371-C1378.
149. Vallance P., Collier J. & Moncada S. (1989a) Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc. Res. 23,1053-1057.
150. Vallance P., Collier J. & Moncada S. (1989b) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997-1000.
151. Vallance P., Leone A., Calver A., Collier J. & Moncada S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575.
152. Vallance P. (1996) Use of L-arginine and its analogs to study nitric oxide pathway in humans. Meth Enzymol. 269, 453-459.
153. Venema R.C., Ju H., Zou R., Ryan J.W. & Venema V.J. (1997) Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J. Biol. Chem. 272, 1276-1282.
154. Vila J., Esplugues J.V., Martinez Cuesta M.A. et al. (1991) NG-monomethyl-L-arginine and NG-nitro-L-arginine inhibit endothelium-dependent relaxations in human isolated omental arteries. J. Pharm. Pharmacol. 43, 869-870.
155. von der Leyen H.E., Gibbons G.H., Morishita R. et al. (1995) Gene therapy inhibiting neointimal vascular lesion, in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92, 1137-1141.
156. Wallerstedt S.M. & Bodelsson M. (1997) Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins, relative contribution of prostanoids, nitric oxide and hyperpolarization. Br. J. Pharmacol. 120, 25-30.
157. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M. & WILCKEN D.E. (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2, 41-45.
158. Wang X.L., Mahaney M.C., Sim A.S. et al. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17, 3147-3153.
159. Wang Y. & Marsden P.A. (1995) Nitric oxide synthases. gene structure and regulation. Adv. Pharmacol. 34, 71-90.
160. Wei C., Jiang S., Lust J.A., Daly R.C. & McGregor C.G. (1996) Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin. Proc. The 71, 346-350.
161. White R.P., Deane C., Vallance P. & Markus H.S. (1998) Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 29, 467-472.
162. Williams D.J., Vallance P.J., Neild G.H., Spencer J.A. & Imms F.J. (1997) Nitric oxide-mediated vasodilation in human pregnancy. Am. J. Physiol. 272, H748-H752.
163. Wilson J.R. & Kapoor S. (1993) Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J. Appl. Physiol. 75, 2740-2744.
164. Wolf Y.G., Rasmussen L.M., Sherman Y., Bundens W.P. & Hye R.J. (1995) Nitroglycerin decreases medial smooth muscle cell proliferation after arterial balloon injury. J. Vasc. Surg. 21, 499-504.
165. Woolfson R.G. & Poston L. (1990) Effect of NG-monomethyl-L-arginine on endothelium-dependent relaxation of human subcutaneous resistance arteries. Clin. Sci. Colch. 79, 273-278.
166. Yang Z.H., Von Segesser L., Bauer E., Stulz P., Turina M. & Luscher T.F. (1991) Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ. Res. 68, 52-60.
167. Yasue H., Matsuyama K., Okumura K., Morikami Y. & Ogawa H. (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81, 482-490.
168. Yasue H., Yoshimura M., Sugiyama S. et al. (1995) Association of a point mutation of the endothelial cell nitric oxide synthase (eNOS) gene with coronary spasm. Circulation 92 (Suppl. I), I-363 (Abstract).
169. Yoshimura M., Yasue H., Nakayama N. et al. (1997) Mutations in the endothelial nitric oxide synthase gene and susceptibility to coronary spasm in the Japanese. Jap. J. Pharm. 75, P-22 (Abstract).
170. Zafari A.M., Ushio-Fukai M., Akers M. et al. (1998) Role of NADH/NADPH oxidase-derived H202 in angiotensin II-induced vascular hypertrophy. Hypertension 32, 488-495.